Canada markets closed

Canopus BioPharma Incorporated (CBIA)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00020.0000 (0.00%)
At close: 03:54PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 557.54k
Enterprise Value 557.54k
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-99.73%
S&P500 52-Week Change 320.07%
52 Week High 30.2240
52 Week Low 30.0001
50-Day Moving Average 30.0004
200-Day Moving Average 30.0007

Share Statistics

Avg Vol (3 month) 3143.13M
Avg Vol (10 day) 347.31M
Shares Outstanding 52.79B
Implied Shares Outstanding 62.79B
Float 8N/A
% Held by Insiders 19.85%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Jul 16, 2007

Financial Highlights

Fiscal Year

Fiscal Year Ends N/A
Most Recent Quarter (mrq)N/A

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)N/A
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A